检索

标题
作者
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E., Dudnikova A.
Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis
Markina M., Milovanova L., Lysenko L., Milovanova S., Volkov A., Beketov V., Lebedeva M., Nezhdanov K., Moiseev S.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V., Pulin A., Mukhin N.
Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy
Mezhonov E., Reitblat O., Vyalkina Y., Airapetian A., Lazareva N., Ageev F., Blankova Z., Svirida O., Prints Y., Zhirov I., Tereshchenko S., Boytsov S.
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review
Mironova O.
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V., Shamkhalova M., Duganova A.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease
Demyanova K., Kozlovskaya N., Korotchaeva Y., Apresyan S., Rylceva L., Usatenko G., Lugovoj A., Vorobyeva M., Bondarenko T., Bespalova A., Volkova O.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G., Tarlovskaia E., Koziolova N., Boldina M., Batiushin M., Ametov A., Arutiunov A., Belevskii A., Galstian G., Grigor’eva N., Dzhunusbekova G., Esaian A., Mal’chikova S., Mit’kovskaia N., Mkrtumian A., Orlova I., Petrova M., Rebrov A., Ruzanov D., Salukhov V., Sisakian A., Skibitskii V., Sugraliev A., Fomin I., Khalimov I., Chesnikova A., Shaposhnik I., Shestakova M.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
What we do and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman’s Day
Piccoli G., Alrukhaimi M., Zhi-Hong L., Zakharova E., Levin A.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S., Karovaikina E., Bulanov N., Moiseev A., Fomin V.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E., Dmitriev V., Titov V.
Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
Chebotareva N., Gulyaev S., Androsova T., Popova E., Gurova D., Novikov P., Milovanova L., Moiseev S.
Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression
Shvetsov M., Zheng A., Kozlovskaya L., Serova A., Travkina E., Mukhin N.
Chronic kidney disease in rheumatoid arthritis patients: prevalence, risks factors, histopathological variants
Chebotareva N., Guliaev S., Androsova T., Milivanova L.
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
Dzgoeva F., Gatagonova T., Bestaeva T., Sopoev M., Bazaeva B., Khamitsaeva O.
Chronic kidney disease and vascular dementia
Mukhin N., Fomin V., Damulin I., Rogova I.
Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies
Proletov I., Saganova E., Galkina O., Zubina I., Bogdanova E., Sipovskiĭ V., Smirnov A.
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F., Remizov O., Botcieva V., Goloeva V., Malakhova N., Ikoeva Z.
Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease
Rudenko T., Kamyshova E., Vasilyeva M., Bobkova I., Solomakhina N., Shvetsov M.
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum
Mukhin N., Glybochko P., Svistunov A., Fomin V., Kiyakbaev G.
Risk factors for cardiovascular system damage in chronic kidney disease
Kutyrina I., Rudenko T., Savel'eva S., Shvetsov M., Vasil'eva M.
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
Mukhin N., Milovanov Y., Kozlovskaya L., Dobrosmyslov I., Milovanova L.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M., Glazunova A., Mikhaleva O., Zuraeva Z., Martynov S., Klefortova I., Manchenko O., Ulyanova I., Ilyin A., Shamkhalova M., Shestakova M.
Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
Dzgoeva F., Sopoev M., Gatagonova T., Bestaeva T., Khamitsaeva O.
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
Pulin A., Kustova T., Fomin V., Mukhin N.
Renal anemia and cardiac remodeling in patient with chronic glomerulonephritis
Murkamilov I., Lunegova O., Kaliev R.
Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region)
Nagaĭtseva S., Shaliagin I., Shvetsov M., Piagaĭ N., Ivanova E., Shilov E.
THE ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME
Kutyrina I., Kryachkova A., Savelieva S.
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F., Remizov O., Goloeva V., Ikoeva Z.
Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies
Saganova E., Zubina I., Bogdanova E., Galkina O., Sipovskii V., Smirnov A.
Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery
Gussaova S., Bobkova I., Yashkov Y., Bordan N., Stavrovskaya E., Bekuzarov D., Evdoshenko V., Fedenko V., Malykhina A., Struve A.
Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks
Murkamilov I., Aitbaev K., Fomin V., Murkamilova Z., Bayzhigitova A.
Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease
Musina N., Semenova R.
REMODELING OF CARDIOVASCULAR SYSTEM AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND OBESITY: ROLE OF GENES ENOS, SUBUNIT P22-PHOX OF NADPH-OXIDASE AND MTHFR
Saginova E., Gallyamov M., Balatsky A., Kolotvin A., Severova M., Samokhodskaya L., Fomin V., Krasnova T., Mukhin N.
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Fomin V.
Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
Gracheva S., Biragova M., Glazunova A., Klefortova I., Shamkhalova M., Dzhavelidze M., Soldatova T., Il'in A., Shestakova M., Tugeeva É., Buziashvili I.
MYOCARDIAL REMODELING RISK FACTORS AT STAGE II-IV CHRONIC KIDNEY DISEASE
Rudenko T., Kutyrina I., Shvetsov M.
Obesity and chronic kidney disease
Bondar' I., Klimontov V., Simakova A., Bondar I., Klimontov V., Simakova A.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M., Frolova N., Kim I., Ushakova A., Usatiuk S., Iskhakov R., Diakova E., Chervinko V., Volodina E., Tomilina N., Kryukov E.
Effect of vitamin D receptor activators on serum Klotho levels in 3b–4 stages chronic кidney disease patients: a prospective randomized study
Milovanova L., Beketov V., Milovanova S., Taranova M., Kozlov V., Pasechnik A., Reshetnikov V., Androsova T., Kalashnikov M.
Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2–5D
Milovanova L., Lysenko (Kozlovskaya) L., Milovanova S., Taranova M., Kozlov V., Reshetnikov V., Lebedeva M., Androsova T., Zubacheva D., Chebotareva N.
Prognostic value of renal resistance index in estimating the progression of chronic kidney disease
Gazhonova V., Zykova A., Chistyakov A., Roshchupkina S., Romanova M., Krasnova T.
Phosphate binders in chronic kidney disease: The positions of sevelamer
Fomin V., Shilov E., Svistunov A., Milovanov I.
ENDOTHELIAL DYSFUNCTION AND APOPTOSIS AT EARLY STAGE OF CHRONIC KIDNEY DISEASE
Smirnov A., Petrischev N., Mnuskina M., Panina I., Pumyantsev A., Vasina E., Achkasova V., Menshutina M.
The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients
Saginova E., Gallyamov M., Severova M., Surkova O., Fomin V., Ermakov N., Rodina A., Mukhin N., Saginova E., Gallyamov M., Severova M., Surkova O., Fomin V., Ermakov N., Rodina A., Mukhin N.
The level of endothelin-1 and reactivity of skin microvessels in patients with early stages of chronic kidney disease
Smirnov A., Petrishchev N., Panina I., Mnuskina M., Achkasova V., Rumyantsev A., Menshutina M., Smirnov A., Petrischev N., Panina I., Mnuskina M., Achkasova V., Rumyantsev A., Menshutina M.
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review
Bulanov N., Moiseev S.
The relationship of hypertriglyceridemia and left ventricular remodeling types in patients with chronic kidney disease
Murkamilov I., Sabirov I., Fomin V., Aitbaev K., Murkamilova Z.
Impact of smoking on kidney transplantation outcomes
Stolyar A., Tomilina N.
The role of immune factors in the progression of chronic kidney diseases in HIV infection
Yushchuk N., Gadzhikulieva M., Balmasova I., Volgina G., Gultyaev M.
The pathogenetic bases of cardiorenal syndrome
Beloglazova I., Mogutova P., Poteshkina N.
Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease
Semenova R., Musina N.
1 - 56 的 56 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##